| MRI-Guided Radiation Therapy in Treating Patients Who Have Undergone Surgery to Remove the Prostate (NCT01028885) | Abramson Cancer Center at Penn Medicine | 2009-06-01 |
| Single and Multiple Ascending Oral Dose Study of RX-10001 in Healthy Volunteers (NCT00941018) | Resolvyx Pharmaceuticals, Inc | 2009-06-01 |
| Pharmacokinetic Interaction Study to Assess the Effect of ASP015K on Tacrolimus in Healthy Volunteers (NCT01430065) | Astellas Pharma Inc | 2009-06-01 |
| Study of PK and Safety of OXC (Oxcarbazepine) XR (Extended Release) as Adjunctive Therapy in Pediatric Epilepsy Patients (NCT00918047) | Supernus Pharmaceuticals, Inc. | 2009-06-01 |
| Phase I Interaction Study of Istaroxime and Digoxin in Subjects With Stable Heart Failure (NCT00869115) | Debiopharm International SA | 2009-06-01 |
| A Double-Dose Safety Study of An Influenza Vaccine (Multimeric-001) (NCT00877448) | BiondVax Pharmaceuticals ltd. | 2009-06-01 |
| Effect of Saffron Supplementation on Macular Cone-mediated Function in Age-related Macular Degeneration (NCT00951288) | Catholic University of the Sacred Heart | 2009-06-01 |
| A Study of Combination of Temsirolimus (Torisel®) and Pegylated Liposomal Doxorubicin (PLD, Doxil®/Caelyx®) in Advanced or Recurrent Breast, Endometrial and Ovarian Cancer (NCT00982631) | Radboud University Medical Center | 2009-06-01 |
| Phase I and Pharmacokinetic Study of Biweekly PEP02 in mCRC Refractory to 1st-line Oxaliplatin Base Therapy (NCT00940758) | PharmaEngine | 2009-06-01 |
| Chronic Electrical Stimulation of Hypothalamus/Fornix in Alzheimer's Disease (NCT00888056) | Centre Hospitalier Universitaire de Nice | 2009-06-01 |
| An Efficacy and Safety Study With Licroca Depot, a Controlled Release Product, Injected Into the Prostate (NCT00913263) | Lidds AB | 2009-06-01 |
| Study to Evaluate the Effects of Neramexane on the Pharmacokinetics of a Combined Drospirenone/Ethinyl Estradiol Oral Contraceptive in Healthy Female Subjects (NCT00915174) | Merz Pharmaceuticals GmbH | 2009-06-01 |
| A Study of MM-111 in Patients With Advanced, Refractory Her2 Amplified, Heregulin Positive Cancers (NCT00911898) | Merrimack Pharmaceuticals | 2009-06-01 |
| Pharmacokinetics and Safety of Posaconazole Tablet in Participants at High Risk for Invasive Fungal Infections (MK-5592-065/P05615) (NCT01777763) | Merck Sharp & Dohme LLC | 2009-06-01 |
| A Trial Investigating the Possible Difference in Development of Type 2 Diabetes Between Caucasian and Japanese Subjects (NCT00897169) | Novo Nordisk A/S | 2009-06-01 |
| Immunization With AFP + GM CSF Plasmid Prime and AFP Adenoviral Vector Boost in Patients With Hepatocellular Carcinoma (NCT00669136) | Lisa H. Butterfield, Ph.D. | 2009-06-01 |
| A Bioequivalence Study of Domestic (Made in China) and Imported Mizolastine Tablets in Healthy Volunteers (NCT01928316) | Xian-Janssen Pharmaceutical Ltd. | 2009-06-01 |
| The Impact of Oligosaccharides and Bifidobacteria on the Intestinal Microflora of Premature Infants (NCT00810160) | University of California, Davis | 2009-06-01 |
| Afatinib and Vinorelbine in Tumours Known to Overexpress EGFR and/or HER2 (NCT00906698) | Boehringer Ingelheim | 2009-06-01 |
| Study of Sirolimus With PEG-Asparaginase in Acute Lymphoblastic Leukemia (ALL) (NCT00957320) | Emory University | 2009-06-01 |
| Everolimus and Docetaxel in Treating Patients With Recurrent, Locally Advanced, or Metastatic Head and Neck Cancer (NCT01313390) | University College, London | 2009-06-01 |
| Effect of CYP3A Genetic Polymorphisms on the Pharmacokinetics of Atorvastatin (NCT00973986) | Liuhuaqiao Hospital | 2009-06-01 |
| Biodegradable Stents in Lung Transplantation (NCT00929942) | Hannover Medical School | 2009-06-01 |
| Duration of P-glycoprotein Inhibition After Oral Administration of HM30181AK Tablet (NCT00954304) | Hanmi Pharmaceutical Company Limited | 2009-06-01 |
| Role of Anti-Inflammatory Agents in Patients With Schizophrenia (NCT00929955) | Pakistan Institute of Living and Learning | 2009-06-01 |
| A Study to Evaluate the Effects of Combining Cabazitaxel With Cisplatin Given Every 3 Weeks in Patients With Advanced Solid Cancer (NCT00925743) | Sanofi | 2009-06-01 |
| CP-690,550 and Midazolam Drug-Drug Interaction Study (NCT00902460) | Pfizer | 2009-06-01 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of APL180 (NCT00907998) | Novartis Pharmaceuticals | 2009-06-01 |
| Open-label Study of Curcumin C-3 Complex in Schizophrenia (NCT01875822) | Woodbury, Michel, M.D. | 2009-06-01 |
| ST266 Versus Standard Care In Treating Partial Thickness Burns (NCT00886470) | Noveome Biotherapeutics, formerly Stemnion | 2009-06-01 |
| Trial of Dasatinib Plus Ixabepilone in 2nd or 3rd Line Metastatic Breast Cancer (NCT00924352) | Accelerated Community Oncology Research Network | 2009-06-01 |
| Non-invasive Imaging of Cetuximab-Zr. 89 Uptake Wit PET: a Phase I Trial in Stage IV Cancer Patients (NCT00691548) | Maastricht Radiation Oncology | 2009-06-01 |
| Study of IMC-EB10 in Participant With Leukemia (NCT00887926) | Eli Lilly and Company | 2009-06-01 |
| T-cell Based Immunotherapy for Head and Neck Cancer (NCT00937300) | Inge Marie Svane | 2009-06-01 |
| Interaction Study SLV337/Simvastatin (NCT00924430) | Solvay Pharmaceuticals | 2009-06-01 |
| ACE527 Safety and Immunogenicity Study (NCT00901654) | TD Vaccines A/S | 2009-06-01 |
| Safety, Tolerability and Pharmacodynamics of CYT013-IL1bQb in Patients With Type 2 Diabetes (NCT00924105) | Cytos Biotechnology AG | 2009-06-01 |
| Effect of BIA 9-1067 on the Pharmacokinetics of Repaglinide (NCT01536366) | Bial - Portela C S.A. | 2009-06-01 |
| Studying Biomarkers in Tumor Tissue and Blood Samples From Patients Undergoing Chemotherapy and Radiation Therapy for Stage II or Stage III Rectal Cancer That Can Be Removed By Surgery (NCT00960427) | Barbara Ann Karmanos Cancer Institute | 2009-06-01 |
| A Pilot Study of the Grapefruit Flavonoid Naringenin for HCV Infection (NCT01091077) | Massachusetts General Hospital | 2009-06-01 |
| Healthy Bodies, Healthy Hearts: A Physical Activity Intervention Trial (NCT01099007) | University of Pittsburgh | 2009-06-01 |
| Dasatinib (Sprycel™) in Patients With Newly Diagnosed Core Binding Factor (CBF) Acute Myeloid Leukemia (AML) (NCT00850382) | University of Ulm | 2009-06-01 |
| T-cell Based Immunotherapy for of Melanoma (NCT00937625) | Inge Marie Svane | 2009-06-01 |
| Individual Dose-escalated Bi-daily Subcutaneously (sc) Ghrelin in Cancer Cachexia: a Phase I/II Study (NCT00933361) | Cantonal Hospital of St. Gallen | 2009-06-01 |
| Single Pass Albumin Dialysis in Patients With Cirrhosis (NCT00764049) | Assistance Publique - Hôpitaux de Paris | 2009-06-01 |
| A Study to Evaluate the Pharmacokinetic Drug Interaction After Oral Concurrent Administration of Fimasartan and Amlodipine in Healthy Male Volunteers (NCT00938197) | Boryung Pharmaceutical Co., Ltd | 2009-06-01 |
| Axillary Lymph Node Preservation Surgery in Reducing Lymphedema in Patients With Breast Cancer (NCT00932035) | City of Hope Medical Center | 2009-06-01 |
| Safety and Mode of Action of a Single Dose and Multiple Doses of Long Acting Activated Recombinant Human Factor VII in Patients With Haemophilia A and B (NCT00922792) | Novo Nordisk A/S | 2009-06-01 |
| Single Dose Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Evaluation of Eplivanserin in Children With Insomnia (NCT00913614) | Sanofi | 2009-06-01 |
| TMC207-TiDP13-C117: Interaction Study in Human Immunodeficiency Virus-type 1 (HIV-1) Infected Patients With Nevirapine (NVP) (NCT00910806) | Tibotec BVBA | 2009-06-01 |
| Effect of BIA 9-1067 on the Pharmacokinetics and Pharmacodynamics of Warfarin (NCT02169440) | Bial - Portela C S.A. | 2009-06-01 |
| Messenger Ribonucleic Acid (mRNA) Transfected Dendritic Cell Vaccination in High Risk Uveal Melanoma Patients (NCT00929019) | Radboud University Medical Center | 2009-06-01 |
| The Therapeutic Effects of Barkley's Parenting Management Program for Taiwanese School-Aged Children With Attention Deficit/Hyperactivity Disorder (ADHD) (NCT00946582) | National Taiwan University Hospital | 2009-06-01 |
| The Impact of Botox® During Robotic Rehabilitation of the Wrist Following Stroke (NCT01088230) | New York Presbyterian Hospital | 2009-06-01 |
| Safety Study to Evaluate KW-2450 in Subjects With Advanced Solid Tumor (NCT00921336) | Kyowa Kirin Co., Ltd. | 2009-06-01 |
| Evidence-Based Medicine Electronic Decision Support Study (NCT00915304) | Tampere University | 2009-06-01 |
| Effect of TU-100 on Gastrointestinal and Colonic Transit in Humans (NCT00871325) | Tsumura USA | 2009-06-01 |
| A Study of RO4998452 in Type 2 Diabetes Patients With Varying Degrees of Renal Impairment (NCT00933972) | Hoffmann-La Roche | 2009-06-01 |
| AZD1981 Bioavailability Study of Intravenous (IV) and Oral Formulations (NCT00918398) | AstraZeneca | 2009-06-01 |
| Compare the Efficacy of Human Albumin With Cabergoline to Prevent Ovarian Hyper Stimulation in Assisted Reproductive Technology (ART) Program (NCT01009567) | Royan Institute | 2009-06-01 |
| Chemotherapy Response Monitoring With 18F-choline PET/CT in Hormone Refractory Prostate Cancer (NCT00928252) | Queen's Medical Center | 2009-06-01 |
| A Phase I Open-Label Study of the Effects of Tacrolimus and Cyclosporine on CP-690,555 in Healthy Volunteers (NCT00860496) | Pfizer | 2009-06-01 |
| Dasatinib or Placebo, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme (NCT00869401) | Alliance for Clinical Trials in Oncology | 2009-06-01 |
| Technetium Tc 99m Demobesin-4 for Imaging Procedures in Patients With Prostate Cancer (NCT00989105) | Cancer Research UK | 2009-06-01 |
| DSP-3025 Study of Healthy Male Volunteers and Seasonal Allergic Rhinitis Male Patients Out of Season (NCT00925678) | Sumitomo Pharma Co., Ltd. | 2009-06-01 |
| A Study to Estimate the Time Course of PF-00241939 Concentration in the Blood Following Dosing by Oral Inhalation From Dry Powder Inhalers (NCT00867282) | Pfizer | 2009-06-01 |
| Study of the Effect of Dapagliflozin on the Pharmacokinetics of Warfarin or Digoxin in Healthy Subjects (NCT00904176) | AstraZeneca | 2009-06-01 |
| Study of CP-675,206 in Bacillus Calmette-Guerin (BCG)-Resistant Bladder Cancer (NCT00880854) | University of Wisconsin, Madison | 2009-06-01 |
| Pharmacokinetics (PK) Study of Once Daily Darunavir/Ritonavir and Twice and Once Daily Raltegravir in HIV-infected Subjects (NCT01047995) | St Stephens Aids Trust | 2009-06-01 |
| Safety and Tolerability Study of Claudiximab in Patients With Advanced Gastroesophageal Cancer (NCT00909025) | Ganymed Pharmaceuticals GmbH | 2009-05-31 |
| A Study of BMS-863233 in Patients With Advanced and/or Metastatic Solid Tumors (NCT00886782) | Bristol-Myers Squibb | 2009-05-31 |
| A Multiple Dose Study of MK-3614 (MK-3614-002) (NCT01033643) | Merck Sharp & Dohme LLC | 2009-05-27 |
| Bivalent Vaccine With Escalating Doses of the Immunological Adjuvant OPT-821, in Combination With Oral β-glucan for High-Risk Neuroblastoma (NCT00911560) | Memorial Sloan Kettering Cancer Center | 2009-05-27 |
| Dose Escalation Study Using Ultra-Hypofractionated, Image-Guided, Intensity-Modulated Radiotherapy in Prostate Cancer (NCT00911118) | Memorial Sloan Kettering Cancer Center | 2009-05-26 |
| A Study of the Safety and Pharmacokinetics of MEGF0444A Administered to Patients With Advanced Solid Tumors (NCT00909740) | Genentech, Inc. | 2009-05-22 |
| Standard Chemotherapy With of Without Axitinib in Malignant Mesothelioma (NCT01211275) | The Netherlands Cancer Institute | 2009-05-22 |
| Phase I Study Of The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Multiple Intravenously Administered Doses Of PF-04236921 In Patients With Rheumatoid Arthritis (NCT00838565) | Pfizer | 2009-05-20 |
| A Drug Interaction Study of SPD503 and Concerta Administered Alone and In Combination in Normal Healthy Volunteers (NCT00901576) | Shire | 2009-05-18 |
| DAS181 Single Dose Escalation Study in Healthy Adults (NCT00876161) | Ansun Biopharma, Inc. | 2009-05-18 |
| A Study to Evaluate the Effect of Single Doses of Drug A (Lamotrigine) and Drug B (Vofopitant) Alone and in Combination on Resting Motor Threshold in Healthy Subjects (NCT00907985) | GlaxoSmithKline | 2009-05-15 |
| Eltrombopag Treatment of Thrombocytopenia in Subjects With Advanced Myelodysplastic Syndrome (MDS) or Secondary Acute Myeloid Leukemia After MDS (sAML/MDS) (NCT00903422) | GlaxoSmithKline | 2009-05-14 |
| First Time in Human Study of GSK1223249 in Amyotrophic Lateral Sclerosis (NCT00875446) | GlaxoSmithKline | 2009-05-13 |
| A Method to Evaluate Glucose-Dependent Insulin Secretion in Healthy Males (MK-0431-179) (NCT00888238) | Merck Sharp & Dohme LLC | 2009-05-12 |
| A Repeat Dose Escalation Study to Investigate the Safety, Tolerability and Pharmacokinetics of GSK1322322 in Healthy Subjects (NCT00896558) | GlaxoSmithKline | 2009-05-11 |
| A Pilot Study of Vaccination With Epitope-Enhanced TARP Peptide and TARP Peptide-Pulsed Dendritic Cells in the Treatment of Stage D0 Prostate Cancer (NCT00972309) | National Cancer Institute (NCI) | 2009-05-11 |
| Dasatinib Plus Radiation Therapy/Temozolomide in Newly-Diagnosed Glioblastoma (NCT00895960) | M.D. Anderson Cancer Center | 2009-05-07 |
| Tethered Capsule Endoscope in Screening Participants for Barrett Esophagus (NCT00903136) | US Department of Veterans Affairs | 2009-05-01 |
| A Study of Dulanermin Administered in Combination With the FOLFOX Regimen and Bevacizumab in Patients With Previously Untreated, Locally Advanced, Recurrent, or Metastatic Colorectal Cancer (NCT00873756) | Genentech, Inc. | 2009-05-01 |
| A Study Evaluating GDC-0980 Administered Once Weekly in Patients With Refractory Solid Tumors or Non-Hodgkin's Lymphoma (NCT00854126) | Genentech, Inc. | 2009-05-01 |
| Study of the Safety, and Sperm and Gonadotropin Suppression of a Contraceptive Gel in Normal Men (NCT00891228) | Premier Research | 2009-05-01 |
| Effects of 2006-RD-05 on Salivary and Serum Immunoglobulin A (IgA) Levels in Healthy Subjects (NCT00906438) | innoVactiv Inc. | 2009-05-01 |
| Determine the Effects of C-administration of AZD7325 and an Oral Contraceptive in Healthy Female Subjects (NCT00901290) | AstraZeneca | 2009-05-01 |
| PEPI-TiDP23-C104 is a First in Human Study With a Single Dose Escalation Part and a Multiple Dosing Part for Compounds TMC589337 and TMC589354. (NCT00908414) | Tibotec Pharmaceuticals, Ireland | 2009-05-01 |
| Relevance of the Ethanol Dose in the Generation of Endogenous Hydroxytyrosol (NCT01788670) | Parc de Salut Mar | 2009-05-01 |
| Deep Brain Stimulation of the Globus Pallidus in Huntington's Disease (NCT00902889) | Heinrich-Heine University, Duesseldorf | 2009-05-01 |
| Bioequivalence Study of Atorvastatin Calcium Tablets, 40 mg Under Fasting Conditions (NCT01645384) | Dr. Reddy's Laboratories Limited | 2009-05-01 |
| Safety and Tolerability of the First IV Dosing of SLV338 in Healthy Volunteers (NCT00885989) | Solvay Pharmaceuticals | 2009-05-01 |
| A Study of Effect of Food on the Pharmacokinetics of a Single JNJ-39823277 (TPI-1062) Dose in Healthy Participants (NCT02103985) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2009-05-01 |
| Safety Study to Evaluate BMS-830216 in Healthy Subjects (NCT00878020) | Bristol-Myers Squibb | 2009-05-01 |
| Study to Assess the Safety of AZD1480 in Patients With Myeloproliferative Diseases (NCT00910728) | AstraZeneca | 2009-05-01 |